CASUS and APACHE II score in predicting mortality after coronary artery bypass grafting.

APACHE II CASUS cardiac surgery mortality.

Journal

Turk gogus kalp damar cerrahisi dergisi
ISSN: 1301-5680
Titre abrégé: Turk Gogus Kalp Damar Cerrahisi Derg
Pays: Turkey
ID NLM: 100887967

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 21 02 2023
accepted: 09 07 2023
medline: 4 9 2023
pubmed: 4 9 2023
entrez: 4 9 2023
Statut: epublish

Résumé

This study aims to compare Cardiac Surgery Score (CASUS) and the Acute Physiology and Chronic Health Evaluation (APACHE II) scoring systems for predicting mortality in patients undergoing isolated coronary artery bypass grafting. Between January 2019 and March 2019, a total of 204 patients (166 males, 38 females; mean age: 60.5±0.7 years; range, 59.2 to 61.9 years) who underwent isolated coronary artery bypass grafting and were monitored at least for 24 h in the intensive care unit postoperatively were included. Pre-, intra-, and postoperative data were recorded. The CASUS and APACHE II scores were calculated using the most abnormal values for each variable during the first 24 h, postoperatively. Clinical outcomes were seven-day mortality and 30-day mortality, need for reintubation, readmission to the intensive care unit, length of intensive care unit stay and length of hospital stay. The 30-day overall mortality was 4.9% (n=10). The CASUS scores were significantly higher for patients developing mortality within 30 days postoperatively (p=0.030) and for patients needing reintubation (p=0.003). In the receiver operating characteristic curve analysis predicting seven-day mortality and prolonged intensive care unit stay, the area under curve was higher for CASUS scoring compared to APACHE II (0.90 The CASUS may prove to be a more reliable scoring system than APACHE II for predicting mortality and morbidity in patients undergoing isolated coronary artery bypass grafting.

Sections du résumé

Background UNASSIGNED
This study aims to compare Cardiac Surgery Score (CASUS) and the Acute Physiology and Chronic Health Evaluation (APACHE II) scoring systems for predicting mortality in patients undergoing isolated coronary artery bypass grafting.
Methods UNASSIGNED
Between January 2019 and March 2019, a total of 204 patients (166 males, 38 females; mean age: 60.5±0.7 years; range, 59.2 to 61.9 years) who underwent isolated coronary artery bypass grafting and were monitored at least for 24 h in the intensive care unit postoperatively were included. Pre-, intra-, and postoperative data were recorded. The CASUS and APACHE II scores were calculated using the most abnormal values for each variable during the first 24 h, postoperatively. Clinical outcomes were seven-day mortality and 30-day mortality, need for reintubation, readmission to the intensive care unit, length of intensive care unit stay and length of hospital stay.
Results UNASSIGNED
The 30-day overall mortality was 4.9% (n=10). The CASUS scores were significantly higher for patients developing mortality within 30 days postoperatively (p=0.030) and for patients needing reintubation (p=0.003). In the receiver operating characteristic curve analysis predicting seven-day mortality and prolonged intensive care unit stay, the area under curve was higher for CASUS scoring compared to APACHE II (0.90
Conclusion UNASSIGNED
The CASUS may prove to be a more reliable scoring system than APACHE II for predicting mortality and morbidity in patients undergoing isolated coronary artery bypass grafting.

Identifiants

pubmed: 37664771
doi: 10.5606/tgkdc.dergisi.2023.24787
pmc: PMC10472474
doi:

Types de publication

Journal Article

Langues

eng

Pagination

343-351

Informations de copyright

Copyright © 2023, Turkish Society of Cardiovascular Surgery.

Déclaration de conflit d'intérêts

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Références

Turk J Anaesthesiol Reanim. 2019 Feb;47(1):41-47
pubmed: 31276110
Am J Crit Care. 2015 Jul;24(4):327-34; quiz 335
pubmed: 26134333
Thorac Cardiovasc Surg. 2018 Nov;66(8):651-660
pubmed: 29316571
Thorac Cardiovasc Surg. 2012 Feb;60(1):35-42
pubmed: 21528470
Semin Cardiothorac Vasc Anesth. 2020 Dec;24(4):304-312
pubmed: 32615890
J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3028-3034
pubmed: 31113712
Ann Thorac Surg. 2005 May;79(5):1555-62
pubmed: 15854933
Med Sci Monit Basic Res. 2015 Jul 03;21:145-52
pubmed: 26137928
J Cardiovasc Surg (Torino). 2018 Apr;59(2):274-281
pubmed: 28741335
J Cardiothorac Surg. 2011 Mar 01;6:21
pubmed: 21362175
J Intensive Care Med. 2022 Oct;37(10):1318-1327
pubmed: 34898329
Eur J Cardiothorac Surg. 2010 Jul;38(1):104-9
pubmed: 20219387
Thorac Cardiovasc Surg. 2010 Oct;58(7):392-7
pubmed: 20922621

Auteurs

Sümeyye Uğur (S)

Department of Anesthesiology and Intensive Care Medicine, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.

Murat Acarel (M)

Department of Anesthesiology and Intensive Care Medicine, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.

Nihan Yapıcı (N)

Department of Anesthesiology and Intensive Care Medicine, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.

Classifications MeSH